IL132761A0 - Crystalline macrolides and process for their preparation - Google Patents

Crystalline macrolides and process for their preparation

Info

Publication number
IL132761A0
IL132761A0 IL13276198A IL13276198A IL132761A0 IL 132761 A0 IL132761 A0 IL 132761A0 IL 13276198 A IL13276198 A IL 13276198A IL 13276198 A IL13276198 A IL 13276198A IL 132761 A0 IL132761 A0 IL 132761A0
Authority
IL
Israel
Prior art keywords
preparation
macrolides
crystalline
crystalline macrolides
Prior art date
Application number
IL13276198A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10815103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL132761(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL132761A0 publication Critical patent/IL132761A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13276198A 1997-06-30 1998-06-26 Crystalline macrolides and process for their preparation IL132761A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9713730.1A GB9713730D0 (en) 1997-06-30 1997-06-30 Organic compounds
PCT/EP1998/003929 WO1999001458A1 (fr) 1997-06-30 1998-06-26 Macrolides cristallins et procede de preparation associe

Publications (1)

Publication Number Publication Date
IL132761A0 true IL132761A0 (en) 2001-03-19

Family

ID=10815103

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13276198A IL132761A0 (en) 1997-06-30 1998-06-26 Crystalline macrolides and process for their preparation

Country Status (32)

Country Link
US (1) US6423722B1 (fr)
EP (1) EP0994880B1 (fr)
JP (2) JP3880634B2 (fr)
KR (1) KR100399765B1 (fr)
CN (1) CN1139595C (fr)
AR (1) AR017754A1 (fr)
AT (1) ATE287410T1 (fr)
AU (1) AU739211B2 (fr)
BR (1) BR9810956A (fr)
CA (1) CA2290412C (fr)
CO (1) CO4940463A1 (fr)
CZ (1) CZ297244B6 (fr)
DE (1) DE69828692T2 (fr)
DK (1) DK0994880T3 (fr)
ES (1) ES2236922T3 (fr)
GB (1) GB9713730D0 (fr)
HK (1) HK1028597A1 (fr)
HU (1) HU227755B1 (fr)
ID (1) ID24897A (fr)
IL (1) IL132761A0 (fr)
MY (1) MY118718A (fr)
NO (1) NO312765B1 (fr)
NZ (1) NZ500994A (fr)
PE (1) PE97699A1 (fr)
PL (1) PL192761B1 (fr)
PT (1) PT994880E (fr)
RU (1) RU2219181C2 (fr)
SK (1) SK285665B6 (fr)
TR (1) TR199903189T2 (fr)
TW (1) TW552264B (fr)
WO (1) WO1999001458A1 (fr)
ZA (1) ZA985655B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
US7875630B2 (en) * 2003-09-03 2011-01-25 Glaxo Group Limited Process salts compositions and use
EP1817314A1 (fr) * 2004-12-01 2007-08-15 Teva Gyógyszergyár Zártköruen Muködo Részvenytarsaság Pimecrolimus amorphe non hygroscopique pulverulent
WO2008057511A2 (fr) * 2006-11-06 2008-05-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Ascomycine et pimécrolimus ayant des niveaux réduits de desméthylascomycine et de 32-désoxy-32-épichloro-desméthylascomycine respectivement, et leurs procédés de préparation
WO2008073757A1 (fr) * 2006-12-07 2008-06-19 Helsinn Healthcare Sa Formes cristallines et amorphes d'hydrochlorure de palonosétron
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
ES2550634T3 (es) 2009-07-10 2015-11-11 Boston Scientific Scimed, Inc. Uso de nanocristales para un balón de suministro de fármaco
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (fr) * 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Procédés de conversion d'une substance médicamenteuse amorphe en une forme cristalline
WO2013028208A1 (fr) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Dispositif médical comprenant un revêtement médicamenteux cristallin
WO2014145780A1 (fr) 2013-03-15 2014-09-18 Biosensors International Group, Ltd. Purification de dérivés de rapamycine
EP3178824A1 (fr) 2015-12-08 2017-06-14 Medichem, S.A. Procédé de préparation de pimecrolimus
CA3060330A1 (fr) * 2017-05-01 2018-11-08 Meda Pharma Gmbh & Co. Kg Procede de conversion d'ascomycine brute en pimecrolimus purifie
EP3741367A1 (fr) 2019-05-21 2020-11-25 Premark Pharma GmbH Traitement de maladies oculaires
WO2024209038A1 (fr) 2023-04-06 2024-10-10 Premark Pharma Gmbh Utilisation de pimecrolimus pour le traitement de la sécheresse oculaire chez des patients caractérisés par un score de coloration cornéenne de 4 ou 5 sur l'échelle de classification d'oxford

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
CY1306A (en) 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
JP2728482B2 (ja) * 1989-01-26 1998-03-18 協和醗酵工業株式会社 マクロライド系抗生物質の精製法
WO1991000865A1 (fr) 1989-07-10 1991-01-24 Gema S.A. Nouvelle forme de cephradine stable, procede de production de celle-ci, et produits intermediaires utilises
NZ235991A (en) * 1989-11-09 1993-05-26 Sandoz Ltd Macrolide compounds and pharmaceutical compositions thereof
JPH05505798A (ja) * 1990-03-13 1993-08-26 フアイソンズ・ピーエルシー 免疫抑制マクロ環状化合物
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
EP0480623A1 (fr) * 1990-10-11 1992-04-15 Merck & Co. Inc. Halomacrolides et dérivés ayant une activité immunosuppressive
ES2100291T3 (es) 1991-07-30 1997-06-16 Ajinomoto Kk Cristales de n-(trans-4-isopropilciclohexilcarbonil)-d-fenilalanina y metodos para prepararlos.
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5221740A (en) 1992-01-16 1993-06-22 American Home Products Corporation Oxepane isomers of rapamycin useful as immunosuppressive agents
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
US5626757A (en) * 1994-02-22 1997-05-06 Advanced Separation Technologies Inc. Macrocyclic antibiotics as separation agents
AU6900596A (en) * 1995-08-24 1997-03-19 Merck & Co., Inc. Process for the preparation of imidazolyl macrolide immunosuppressants
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds

Also Published As

Publication number Publication date
SK285665B6 (sk) 2007-05-03
US6423722B1 (en) 2002-07-23
DK0994880T3 (da) 2005-05-30
GB9713730D0 (en) 1997-09-03
HUP0003053A2 (hu) 2001-02-28
CZ474099A3 (cs) 2000-04-12
CZ297244B6 (cs) 2006-10-11
JP4504323B2 (ja) 2010-07-14
PT994880E (pt) 2005-06-30
JP3880634B2 (ja) 2007-02-14
DE69828692T2 (de) 2006-01-12
TR199903189T2 (xx) 2000-06-21
AR017754A1 (es) 2001-10-24
ZA985655B (en) 1998-12-30
NO995909D0 (no) 1999-12-02
JP2006151999A (ja) 2006-06-15
KR20010020423A (ko) 2001-03-15
CA2290412A1 (fr) 1999-01-14
PE97699A1 (es) 1999-10-29
TW552264B (en) 2003-09-11
AU8540998A (en) 1999-01-25
ID24897A (id) 2000-08-31
PL336719A1 (en) 2000-07-03
WO1999001458A1 (fr) 1999-01-14
RU2219181C2 (ru) 2003-12-20
BR9810956A (pt) 2000-09-26
HK1028597A1 (en) 2001-02-23
NZ500994A (en) 2001-08-31
MY118718A (en) 2005-01-31
EP0994880B1 (fr) 2005-01-19
JP2001506279A (ja) 2001-05-15
AU739211B2 (en) 2001-10-04
ATE287410T1 (de) 2005-02-15
HU227755B1 (en) 2012-02-28
NO995909L (no) 1999-12-02
PL192761B1 (pl) 2006-12-29
SK186699A3 (en) 2000-05-16
DE69828692D1 (de) 2005-02-24
CN1261365A (zh) 2000-07-26
KR100399765B1 (ko) 2003-09-29
CO4940463A1 (es) 2000-07-24
CA2290412C (fr) 2009-11-10
NO312765B1 (no) 2002-07-01
ES2236922T3 (es) 2005-07-16
EP0994880A1 (fr) 2000-04-26
HUP0003053A3 (en) 2003-03-28
CN1139595C (zh) 2004-02-25

Similar Documents

Publication Publication Date Title
GB2331518B (en) Erythromycins and process for their preparation
HUP0100420A3 (en) Novel macrolides and process for preparing them
HUP9800208A3 (en) Omega-cycloalkyl-prostaglandin e2-derivatives and process for preparing them
PL337606A1 (en) Derivatives of erythromycin 9-oxime
IL132761A0 (en) Crystalline macrolides and process for their preparation
IL125622A0 (en) Novel erythromycin derivatives method for preparing same and use thereof as drugs
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
CZ20012118A3 (cs) Způsob výroby 3-alkanoylindolu a 3-alkylindolu
PL324346A1 (en) Macrolides
IL126839A0 (en) Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation
EP0970065A4 (fr) Antibiotiques et leur procede de preparation
EP0846697A4 (fr) Procede d'elaboration de derives d'erythromycine
IL128182A0 (en) Novel erythromycin derivatives method for preparing same and use thereof as drugs
EP1044985A4 (fr) Derives d'erythromycine
EP0884322A4 (fr) Processus de preparation de derives d'erythromycine
AU6168294A (en) Triplex-forming paired-ion oligonucleotides and methods for preparing and using same
HUP0002717A3 (en) 13-deoxyanthracycline derivatives and processes for preparing them
HK1025951A1 (en) Cephalonsporin crystals and process for their preparation
IL129330A (en) Phenoxy-phenylsulfonic acid derivatives and process for their preparation
AU7241398A (en) Construction element and process for its preparation
PL319673A1 (en) Biphenoles preparation process
HUP9902905A3 (en) Erythromycins and process for their preparation
GB9700851D0 (en) Dihydrophenanthrenone derivatives and process for their preparation
ZA983808B (en) Process for preparation of azithromycin
HUP9902893A3 (en) 6-0-substituted erythromycin compounds and method for making same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired